Skip to main content
NCBI home page
Gut logoLink to Gut
. 1999 Oct;45(4):475–476. doi: 10.1136/gut.45.4.475

Long term outcome of liver transplantation for viral hepatitis: is there a need to re-evaluate patient selection?

D MUTIMER 1
PMCID: PMC1727668  PMID: 10486345

Full Text

The Full Text of this article is available as a PDF (49.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bartholomew M. M., Jansen R. W., Jeffers L. J., Reddy K. R., Johnson L. C., Bunzendahl H., Condreay L. D., Tzakis A. G., Schiff E. R., Brown N. A. Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation. Lancet. 1997 Jan 4;349(9044):20–22. doi: 10.1016/S0140-6736(96)02266-0. [DOI] [PubMed] [Google Scholar]
  2. Bizollon T., Palazzo U., Ducerf C., Chevallier M., Elliott M., Baulieux J., Pouyet M., Trepo C. Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation. Hepatology. 1997 Aug;26(2):500–504. doi: 10.1002/hep.510260236. [DOI] [PubMed] [Google Scholar]
  3. Charlton M., Seaberg E., Wiesner R., Everhart J., Zetterman R., Lake J., Detre K., Hoofnagle J. Predictors of patient and graft survival following liver transplantation for hepatitis C. Hepatology. 1998 Sep;28(3):823–830. doi: 10.1002/hep.510280333. [DOI] [PubMed] [Google Scholar]
  4. Davies S. E., Portmann B. C., O'Grady J. G., Aldis P. M., Chaggar K., Alexander G. J., Williams R. Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis. Hepatology. 1991 Jan;13(1):150–157. [PubMed] [Google Scholar]
  5. Fattovich G., Giustina G., Degos F., Tremolada F., Diodati G., Almasio P., Nevens F., Solinas A., Mura D., Brouwer J. T. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology. 1997 Feb;112(2):463–472. doi: 10.1053/gast.1997.v112.pm9024300. [DOI] [PubMed] [Google Scholar]
  6. Féray C., Gigou M., Samuel D., Paradis V., Mishiro S., Maertens G., Reynés M., Okamoto H., Bismuth H., Bréchot C. Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation. Gastroenterology. 1995 Apr;108(4):1088–1096. doi: 10.1016/0016-5085(95)90207-4. [DOI] [PubMed] [Google Scholar]
  7. Féray C., Gigou M., Samuel D., Paradis V., Wilber J., David M. F., Urdea M., Reynes M., Bréchot C., Bismuth H. The course of hepatitis C virus infection after liver transplantation. Hepatology. 1994 Nov;20(5):1137–1143. doi: 10.1002/hep.1840200506. [DOI] [PubMed] [Google Scholar]
  8. Gane E. J., Portmann B. C., Naoumov N. V., Smith H. M., Underhill J. A., Donaldson P. T., Maertens G., Williams R. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med. 1996 Mar 28;334(13):815–820. doi: 10.1056/NEJM199603283341302. [DOI] [PubMed] [Google Scholar]
  9. Grellier L., Mutimer D., Ahmed M., Brown D., Burroughs A. K., Rolles K., McMaster P., Beranek P., Kennedy F., Kibbler H. Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis. Lancet. 1996 Nov 2;348(9036):1212–1215. doi: 10.1016/s0140-6736(96)04444-3. [DOI] [PubMed] [Google Scholar]
  10. Harrison R. F., Davies M. H., Goldin R. D., Hubscher S. G. Recurrent hepatitis B in liver allografts: a distinctive form of rapidly developing cirrhosis. Histopathology. 1993 Jul;23(1):21–28. doi: 10.1111/j.1365-2559.1993.tb01179.x. [DOI] [PubMed] [Google Scholar]
  11. Ling R., Mutimer D., Ahmed M., Boxall E. H., Elias E., Dusheiko G. M., Harrison T. J. Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine. Hepatology. 1996 Sep;24(3):711–713. doi: 10.1002/hep.510240339. [DOI] [PubMed] [Google Scholar]
  12. Markowitz J. S., Martin P., Conrad A. J., Markmann J. F., Seu P., Yersiz H., Goss J. A., Schmidt P., Pakrasi A., Artinian L. Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin. Hepatology. 1998 Aug;28(2):585–589. doi: 10.1002/hep.510280241. [DOI] [PubMed] [Google Scholar]
  13. Mutimer D., Pillay D., Dragon E., Tang H., Ahmed M., O'Donnell K., Shaw J., Burroughs N., Rand D., Cane P. High pre-treatment serum hepatitis B virus titre predicts failure of lamivudine prophylaxis and graft re-infection after liver transplantation. J Hepatol. 1999 Apr;30(4):715–721. doi: 10.1016/s0168-8278(99)80204-9. [DOI] [PubMed] [Google Scholar]
  14. Müller R., Gubernatis G., Farle M., Niehoff G., Klein H., Wittekind C., Tusch G., Lautz H. U., Böker K., Stangel W. Liver transplantation in HBs antigen (HBsAg) carriers. Prevention of hepatitis B virus (HBV) recurrence by passive immunization. J Hepatol. 1991 Jul;13(1):90–96. doi: 10.1016/0168-8278(91)90869-d. [DOI] [PubMed] [Google Scholar]
  15. Poynard T., Marcellin P., Lee S. S., Niederau C., Minuk G. S., Ideo G., Bain V., Heathcote J., Zeuzem S., Trepo C. Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT) Lancet. 1998 Oct 31;352(9138):1426–1432. doi: 10.1016/s0140-6736(98)07124-4. [DOI] [PubMed] [Google Scholar]
  16. Samuel D., Muller R., Alexander G., Fassati L., Ducot B., Benhamou J. P., Bismuth H. Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med. 1993 Dec 16;329(25):1842–1847. doi: 10.1056/NEJM199312163292503. [DOI] [PubMed] [Google Scholar]
  17. Schluger L. K., Sheiner P. A., Thung S. N., Lau J. Y., Min A., Wolf D. C., Fiel I., Zhang D., Gerber M. A., Miller C. M. Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation. Hepatology. 1996 May;23(5):971–976. doi: 10.1002/hep.510230505. [DOI] [PubMed] [Google Scholar]
  18. Sheiner P. A., Boros P., Klion F. M., Thung S. N., Schluger L. K., Lau J. Y., Mor E., Bodian C., Guy S. R., Schwartz M. E. The efficacy of prophylactic interferon alfa-2b in preventing recurrent hepatitis C after liver transplantation. Hepatology. 1998 Sep;28(3):831–838. doi: 10.1002/hep.510280334. [DOI] [PubMed] [Google Scholar]
  19. Sheiner P. A., Schluger L. K., Emre S., Thung S. N., Lau J. Y., Guy S. R., Schwartz M. E., Miller C. M. Retransplantation for recurrent hepatitis C. Liver Transpl Surg. 1997 Mar;3(2):130–136. doi: 10.1002/lt.500030205. [DOI] [PubMed] [Google Scholar]
  20. Shuhart M. C., Bronner M. P., Gretch D. R., Thomassen L. V., Wartelle C. F., Tateyama H., Emerson S. S., Perkins J. D., Carithers R. L., Jr Histological and clinical outcome after liver transplantation for hepatitis C. Hepatology. 1997 Dec;26(6):1646–1652. doi: 10.1002/hep.510260638. [DOI] [PubMed] [Google Scholar]
  21. Tipples G. A., Ma M. M., Fischer K. P., Bain V. G., Kneteman N. M., Tyrrell D. L. Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo. Hepatology. 1996 Sep;24(3):714–717. doi: 10.1002/hep.510240340. [DOI] [PubMed] [Google Scholar]
  22. Vargas H. E., Laskus T., Wang L. F., Radkowski M., Poutous A., Lee R., Demetris J. A., Gayowski T., Marino I. R., Singh N. The influence of hepatitis C virus genotypes on the outcome of liver transplantation. Liver Transpl Surg. 1998 Jan;4(1):22–27. doi: 10.1002/lt.500040103. [DOI] [PubMed] [Google Scholar]
  23. Wiesner R. H., Krom R. A. Liver transplantation for hepatitis B: the con aspect. Liver Transpl Surg. 1995 Jul;1(4):265–270. doi: 10.1002/lt.500010415. [DOI] [PubMed] [Google Scholar]
  24. Zhou S., Terrault N. A., Ferrell L., Hahn J. A., Lau J. Y., Simmonds P., Roberts J. P., Lake J. R., Ascher N. L., Wright T. L. Severity of liver disease in liver transplantation recipients with hepatitis C virus infection: relationship to genotype and level of viremia. Hepatology. 1996 Nov;24(5):1041–1046. doi: 10.1002/hep.510240510. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES